News
-
-
PRESS RELEASE
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Wellgistics Health, Inc. announces non-binding Letter of Intent to acquire Neuritek Therapeutics, a neuroscience-focused research organization, enhancing its healthcare platform -
-
PRESS RELEASE
Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network
Wellgistics Health launches Brenzavvy to target the $16 billion SGLT-2 inhibitor market, focusing on patient education and reduced costs. Proprietary EinsteinRx AI platform supports broader market access and enhanced care experience for diabetics -
-
PRESS RELEASE
Wellgistics Health Announces that it will Distribute a Dream Bowl 2026 Meme Coin to Wellgistics Health Stockholders
Wellgistics Health, Inc. sets record date for Dream Bowl 2026 Meme Coin distribution to shareholders, to optimize prescription medicines journey using blockchain technology -
-
PRESS RELEASE
Wellgistics Health Announces Sponsorship of Dream Bowl 2026 and Participation in DataVault AI Dream Bowl 2026 Meme Coin Shareholder Distribution Plan
Wellgistics Health, Inc. sponsors Dream Bowl 2026 & plans to distribute Dream Bowl 2026 Meme Coin to shareholders. DataVault AI Shareholder Distribution Plan involvement announced -
-
PRESS RELEASE
Wellgistics Health to Report Third Quarter 2025 Financial Results and Provide a Business Update on the morning of Thursday, November 20th, 2025
Wellgistics Health, Inc. to report Q3 2025 financial results and business update on November 20, 2025. Wellgistics optimizes medication delivery with integrated technology platform